Top Midday Decliners
1:58PM ET 4/14/2022 MT NewswiresProtagonist Therapeutics (PTGX) said it received a letter from the Food and Drug Administration indicating the regulator's intention to rescind...
Protagonist Therapeutics (PTGX) said it received a letter from the Food and Drug Administration indicating the regulator's intention to rescind...
Evolving Systems (EVOL) said it formally notified the Nasdaq Stock Market of its plan for a voluntarily delisting. The company said early on Thursday that...
Karen Singer, 10% Owner, on February 22, 2022, executed a purchase for 70,628 shares in Evolving Systems (EVOL) for $125,833. Following the Form 4 filing...
Karen Singer, 10% Owner, on January 31, 2022, executed a purchase for 1,164,870 shares in Evolving Systems (EVOL) for $2,687,258. Following the Form 4...
Address | 9800 Pyramid Court Englewood, Colorado 80112 |
Phone | +1.303.802.1000 |
Number of Employees | 280 |
Recent SEC Filing | 08/12/2022![]() |
Executive Chairman, President & CEO | Matthew Stecker |
Secretary & Senior Vice President-Finance | Mark Paul Szynkowski |
Senior Vice President-Sales | Richard Lewis |
Investor Relations Contact | Alice Ahern |
Price Open | $1.49 |
Previous Close | $1.50 |
52 Week Range | $0.84 - 2.86 |
Market Capitalization | $18.5 M |
Shares Outstanding | 12.3 M |
Sector | Technology Services |
Industry | Information Technology Services | Next Earnings Announcement | 08/18/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | $0.001 |
Beta vs. S&P 500 | N/A |
Revenue | $30.6 M |
Net Profit Margin | -2.10% |
Return on Equity | -2.59% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |